Has Andrew Hirsh, MD received payments from drug or device companies?

Yes. Drug and device makers reported $23,467 in general payments to Andrew Hirsh, MD across 65 transactions between 2019–2025. Most Open Payments records nationally are meals worth under $20; a reported payment is not evidence of wrongdoing.

Does a payment mean Andrew Hirsh, MD did something wrong?

No. Federal law requires drug and device makers to report almost every transfer of value to a physician, including a $14 sandwich at a lunch presentation. Consulting fees, research funding and royalties to device inventors are ordinary, legal parts of medicine. This site reports what was disclosed; it makes no allegation.

Where does this information about Andrew Hirsh, MD come from?

The U.S. Centers for Medicare & Medicaid Services. Payments come from Open Payments, published under the Physician Payments Sunshine Act. Billing and prescribing figures come from the Medicare Physician & Other Practitioners and Part D Prescriber public use files for 2024.

Andrew Hirsh, MD

Urology · Somers Point, NJNPI 1912182189

Payments from drug & device makers

What this record shows

The money is spread across several categories — speaking fees (27.1%), consulting fees and education — rather than concentrated in one kind of arrangement. 15 manufacturers reported payments, led by Neotract Inc. at 33.3% of the total. Reporting peaked in 2019 at $17,791 and has fallen 98.9% since, to $195 in 2025. Among urology clinicians in NJ with any reported payments, this total sits in the top 10% — high for the specialty, which is a reason to read the composition above rather than the number alone.

$23,467in general payments, 2019–2025

Across 65 payments — averaging $361.03 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.

Neotract Inc.$8K
Procept Biorobotics Corporation$8K
Intuitive Surgical$5K
Uromedica, Incorporated$2K
Boston Scientific$200
Calyxo, Inc.$195
plus $461 from 9 others

$46,610in research payments, 2019–2025

Across 1 payment — averaging $46,610 each. Payments tied to a research study. These frequently flow through the physician to a hospital or research institution rather than to the physician personally.

Neotract Inc.$47K

What the payments were for

Consulting fees$6,00026%
Speaking & faculty fees$6,35027%
Travel & lodging$3,98517%
Food & beverage$2,51511%
Education$4,61720%

General payments by program year

Who reported the general payments

Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.

Company	Payments	Total
Neotract Inc.	16	$7,822
Procept Biorobotics Corporation	10	$7,614
Intuitive Surgical	14	$4,928
Uromedica, Incorporated	3	$2,248
Boston Scientific	5	$200
Calyxo, Inc.	2	$195
Palette Life Sciences, Inc.	3	$146
Pfizer	1	$91
AbbVie	4	$54
Teleflex LLC	2	$49
Baxter Healthcare	1	$36
Medtronic	1	$27
Impel Pharmaceuticals Inc.	1	$24
SRS Medical Systems, Inc.	1	$20
Olympus America Inc.	1	$16

What the payments were tied to

Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.

How this compares

$23,467 in reported general payments places this provider in the 90th percentile of 401 urology providers in New Jersey.

See all urology providers in New Jersey →

Medicare billing

Part B allowed, 2024

$248,263

Medicare patients

745

Services billed

2,563

What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.

Most prescribed under Part D

Drug	Claims	Cost to plans & patients
MyrbetriqMirabegron	14	$13,869
Tamsulosin Hcl	296	$5,020
Alfuzosin Hcl ErAlfuzosin Hcl	40	$1,248
Finasteride	51	$1,096
Cefpodoxime Proxetil	32	$496
Cephalexin	72	$207
Ciprofloxacin Hcl	57	$181
Phenazopyridine Hcl	22	$146
Oxybutynin Chloride	14	$95
Sulfamethoxazole-TrimethoprimSulfamethoxazole/Trimethoprim	18	$44

Paid to pharmacies, not to this prescriber.

Other urology in Somers Point

Michael StifelmanHackensack$1.4M
Gordon BrownCherry Hill$1.3M
Thomas MuellerLinwood$1.1M
David SussmanLinwood$802K
Michael IngberDenville$530K
Ravi MunverHackensack$529K
Grannum SantBridgewater$487K
Mutahar AhmedMaywood$414K
Kevin GioiaRumson$143K
Robert SimonCliffside Park$108K

See the full list for New Jersey →

Where these figures come from

Payments: CMS Open Payments, program years 2019–2025 (publication P06302026_06032026).
Billing: Medicare Physician & Other Practitioners, data year 2024. Original Medicare Part B only.
Identity: NPPES NPI Registry, July 2026.

Is this you, or does something look wrong? →